Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Launch of equity placing of approximately US$10m

March 12, 2024
RNS Number : 4874G Renalytix PLC 12 March 2024   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ,  AUSTRALIA , CANADA , JAPAN , NEW ZEALAND OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION IN WHICH OFFERS OR

Form 8.3 - Renalytix Plc

March 11, 2024
RNS Number : 4118G TCM Wealth Limited 11 March 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: TCM

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 11, 2024
RNS Number : 3418G Stifel Nicolaus Europe Limited 11 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

FORM 8 (OPD) - Renalytix plc

March 8, 2024
RNS Number : 1928G Renalytix PLC 08 March 2024       Renalytix plc   (" Renalytix plc " or the "Company")     FORM 8 (OPD)   PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code")   1.            KEY INFORMATION   (a) Full name of discloser:

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 8, 2024
RNS Number : 1669G Stifel Nicolaus Europe Limited 08 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Form 8.3 - Renalytix Plc

March 8, 2024
RNS Number : 1754G Harwood Capital LLP 08 March 2024     FORM 8.3     PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser:

Polar Capital Hldgs - Form 8.3 - RENALYTIX PLC

March 6, 2024
RNS Number : 8935F Polar Capital Holdings PLC 06 March 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 6, 2024
RNS Number : 8156F Stifel Nicolaus Europe Limited 06 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Form 8.3 - Renalytix Plc

March 5, 2024
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.            KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 5, 2024
RNS Number : 6301F Stifel Nicolaus Europe Limited 05 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name
Displaying 51 - 60 of 347